A “significant breakthrough” in HIV prevention could be on the horizon, according to the World Health Organization. Results of an interim analysis from a Phase 3 clinical trial sponsored by Gilead Sciences, Inc., showed that lenacapavir, a twice-yearly injectable drug, is a highly promising tool for thwarting new HIV infections. Here, Onyema Ogbuagu, associate professor of...
Tag: <span>HIV drugs</span>
Post
Research breakthrough could see HIV drugs used to treat low-grade brain tumors
by University of Plymouth Credit: Pixabay/CC0 Public Domain Drugs developed to treat AIDS and HIV could offer hope to patients diagnosed with the most common form of primary brain tumor. The breakthrough, co-funded by the charity Brain Tumor Research, is significant because, if further research is conclusive, the anti-retroviral drugs could be prescribed for patients...
Post
Common HIV drugs may prevent leading cause of vision loss, study finds
by University of Virginia Jayakrishna Ambati, MD, and his collaborators have identified a group of drugs that may help stop a leading cause of vision loss after making an unexpected discovery that overturns a fundamental belief about DNA. Credit: UVA Health Scientists have identified a group of drugs that may help stop a leading cause of...
Post
HIV drugs could prevent diabetes, study suggests
UNIVERSITY OF VIRGINIA HEALTH SYSTEM IMAGE: JAYAKRISHNA AMBATI, MD, AND COLLEAGUES FOUND THAT PATIENTS TAKING DRUGS CALLED NRTIS TO TREAT HIV AND HEPATITIS B HAD A 33% LOWER RISK OF DEVELOPING DIABETES. A group of drugs used to treat HIV and hepatitis B could be repurposed to prevent type 2 diabetes, a new study suggests. ...
Post
Clinical trial shows HIV drugs ineffective against COVID-19
by Bob Yirka , Medical Xpress A team of doctors and researchers in China has found that drugs that are effective in treating patients with HIV are ineffective against COVID-19. In their paper published in The New England Journal of Medicine, the group describes the clinical trial they conducted with patients in Wuhan, China, and...
Post
Charlie Sheen ‘suffered borderline dementia from his old HIV drugs’ – that he says was cured by new drug in a clinical trial
Sheen, 51, revealed his HIV-positive diagnosis in November 2015 In early 2016, he joined a Phase III clinical trial for PRO-140, an intravenous injection that is done once a week, rather than taking daily pills Last year Sheen told Daily Mail Online he experienced a ‘transformation’ after switching from the ‘cocktail of drugs’ to PRO-140...